CLASS II ONGOING Device recall · Reported 9 Jul 2025 · FDA Enforcement Report

REF: 123400,Bard Urologist's Tray, For the Obstructed Urethra recalled

C.R. Bard is recalling REF: 123400,Bard Urologist's Tray, For the Obstructed Urethra, distributed nationwide in the US. The recall was initiated on 3 Jun 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # NGJX2513/UDI: 00801741000294
Quantity recalled63 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2076-2025
FDA event ID
96961
Recalling firm
C.R. Bard, Covington, GA
Classification
Class II
Status
Ongoing
Recall initiated
3 Jun 2025
FDA classified
3 Jul 2025
Reported
9 Jul 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

3 Jun 2025Recall initiated by company
3 Jul 2025Classified by FDA+30 days
9 Jul 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cather packaging may contain the incorrect French size.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

REF: 123400,Bard Urologist's Tray, For the Obstructed Urethra

Where it was distributed

Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, FL, GA, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, VT, WI, WV and the country of Canada.

Nationwide AlabamaArkansasArizonaCaliforniaColoradoFloridaGeorgiaIllinoisIndianaKentuckyLouisianaMassachusettsMarylandMaineMichiganMinnesotaMissouriMississippiMontanaNorth Carolina

Questions about this recall

Why was it recalled?

Cather packaging may contain the incorrect French size.

Which lots are affected?

Lot # NGJX2513/UDI: 00801741000294

Where was it sold?

Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, FL, GA, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, VT, WI, WV and the country of Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 96961

More recalls from C.R. Bard

All 123

Other Other Medical Devices recalls

All 13,857